May 8, 2018, Lawrence, MA – Rubix LS is announcing today the launch of its new Data & Research division to its core business function. This is a step for Rubix LS to strongly position its expertise base to move as a technological think tank.
With the addition of its new Data & Research division, Rubix LS will be looking to expand its ability to be inclusive of predictive data aggregation and analysis that are indicators for transforming industries.
“The inclusion of our new Data & Research division transforms the way we look at the long view of innovation” says Stacy Arrazcaeta, head of business development for Rubix LS “It’s no longer enough to be great at being subject matter experts in fields to support projects, if we’re looking to transform an industry, we have to also proactively engage with what are the next strong opportunities for the world to harness”
This move, the Rubix LS Data & Research division will be putting an emphasis on current research and reporting gaps from: cancer & scientific analysis, emerging technologies, research and development trends, and market optimization. Clients will be able to engage within Rubix LS Data & Research division through purchase of branded industry reports, custom reports, and a subscription model for deep trends and analysis utilizing our database.
About Rubix LS:
Rubix LS., was founded in 2016 to merge advanced technologies in the life-science arena to advance the therapy options for patients who are diagnosed with rare and orphan diseases. Rubix LS is developing combinatory devices, varied within specialty technologies, that utilizes compounds and materials from regeneration to nanoparticles and turning them into agents of change for the human health and the world around us.
Some statements in this press release are not historical facts and constitute “forward-looking statements” within the meaning of the “safe-harbor” provisions of the Private Securities Litigation Reform Act of 1995 that are based on current expectations of the company’s management. Forward-looking statements are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. The company does not undertake to update forward-looking statements to reflect a change in its views, events or circumstances that occur after the date of this release.